DVN
18
2
LH
45
3
NAVI
47
3
AMGN
38
-6
XYL
45
8
FMC
33
2
SRE
66
3
ESS
64
4
AKAM
50
7
AVY
50
2
KO
44
2
AAL
53
-4
PGR
63
3
EXPD
45
8
D
45
5
FRT
45
6
ADP
66
2
ADSK
68
2
ABBV
39
8
DD
60
4
DVN
18
2
LH
45
3
NAVI
47
3
AMGN
38
-6
XYL
45
8
FMC
33
2
SRE
66
3
ESS
64
4
AKAM
50
7
AVY
50
2
KO
44
2
AAL
53
-4
PGR
63
3
EXPD
45
8
D
45
5
FRT
45
6
ADP
66
2
ADSK
68
2
ABBV
39
8
DD
60
4
Financhill
Back

Entrada Therapeutics Quote, Financials, Valuation and Earnings

Invest. Do Good. Get Rewarded. Just $0.26/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
58

TRDA
Entrada Therapeutics

Last Price:
18.85
Seasonality Move:
-29.61%

7 Day Trial

ALL ACCESS PASS

$ 7

Trade on Tuesday. Profit on Friday. Rinse & Repeat

Get the full details now.

Entrada Therapeutics Price Quote

$18.85
+0.80 (+4.43%)
(Updated: November 22, 2024 at 5:55 PM ET)

Entrada Therapeutics Key Stats

Buy
58
Entrada Therapeutics (TRDA) is a Buy
Day range:
$17.60 - $18.40
52-week range:
$10.75 - $20.49
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
3.03
P/B ratio:
1.6%
Volume:
85K
Avg. volume:
123.6K
1-year change:
8.28%
Market cap:
$675.4M
Revenue:
$129M
EPS:
$1.59

How Much Does Entrada Therapeutics Make?

Is Entrada Therapeutics Growing As A Company?

  • What Is Entrada Therapeutics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is -0.55%
  • What Is Entrada Therapeutics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Entrada Therapeutics Stock Price Performance

What Is Entrada Therapeutics 52-Week High & Low?

Entrada Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Entrada Therapeutics?

Is Entrada Therapeutics Cash Flow Positive?

  • What Is TRDA Cash Flow From Operations?
    Cash flow from operations (TTM) is -$14M
  • What Is Entrada Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $102.3M
  • What Is Entrada Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$62.1M

Entrada Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    TRDA return on invested capital is 17.06%
  • What Is Entrada Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is 10.56%
  • What Is TRDA Return On Equity?
    ROE is a measure of profitability and is 17.06%

Entrada Therapeutics Earnings Date & Stock Price

Entrada Therapeutics Competitors

Entrada Therapeutics Dividend Yield

Entrada Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 44%
Revenue: -55.25% 64.8%

Analyst Recommendations

Buy Recommendations: 4
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 25.57
Upside from Last Price: 41.66%

Major Shareholders

  • How many TRDA shares are owned by institutional investors?
    42.7M TRDA shares are owned by institutional investors
  • How many TRDA shares are owned by insiders?
    860K TRDA shares are owned by insiders